Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
3.020
+0.010 (0.33%)
At close: Jun 23, 2026, 4:00 PM EDT
3.000
-0.020 (-0.66%)
After-hours: Jun 23, 2026, 7:35 PM EDT
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $492.43 million as of June 23, 2026. Its market cap has increased by 291.30% in one year.
Market Cap
492.43M
Enterprise Value
402.24M
1-Year Change
291.30%
Ranking
Category
Stock Price
$3.02
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $235.53M to $492.43M, an increase of 109.07%. That is a compound annual growth rate of 11.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 492.43M | 133.58% |
| Dec 31, 2025 | 210.82M | 90.01% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 490.98M |
| Kyverna Therapeutics | 490.62M |
| Assembly Biosciences | 484.33M |
| Artiva Biotherapeutics | 477.14M |
| Prothena Corporation | 467.51M |
| C4 Therapeutics | 458.85M |
| Monopar Therapeutics | 451.97M |
| Contineum Therapeutics | 446.39M |